MEI PHARMA INC's ticker is MEIP and the CUSIP is 55279B202. A total of 106 filers reported holding MEI PHARMA INC in Q3 2020. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $894,000 | -12.7% | 307,313 | -4.9% | 0.00% | -100.0% |
Q2 2021 | $1,024,000 | +31.5% | 323,089 | +37.6% | 0.00% | 0.0% |
Q1 2021 | $779,000 | +1.4% | 234,731 | -8.3% | 0.00% | 0.0% |
Q4 2020 | $768,000 | +5020.0% | 255,843 | +5267.0% | 0.00% | – |
Q3 2020 | $15,000 | -46.4% | 4,767 | -42.2% | 0.00% | – |
Q2 2020 | $28,000 | +21.7% | 8,242 | -9.3% | 0.00% | – |
Q4 2019 | $23,000 | +130.0% | 9,085 | +51.9% | 0.00% | – |
Q3 2019 | $10,000 | -28.6% | 5,979 | +5.1% | 0.00% | – |
Q2 2019 | $14,000 | -88.1% | 5,688 | -87.0% | 0.00% | – |
Q3 2017 | $118,000 | -6.3% | 43,816 | -17.2% | 0.00% | – |
Q2 2017 | $126,000 | +6200.0% | 52,892 | +17530.7% | 0.00% | – |
Q2 2014 | $2,000 | -97.2% | 300 | -95.3% | 0.00% | – |
Q1 2014 | $71,000 | +39.2% | 6,326 | 0.0% | 0.00% | – |
Q4 2013 | $51,000 | -10.5% | 6,326 | +25.3% | 0.00% | – |
Q3 2013 | $57,000 | +58.3% | 5,048 | 0.0% | 0.00% | – |
Q2 2013 | $36,000 | – | 5,048 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CAXTON CORP | 3,459,124 | $9,132,000 | 11.08% |
Sio Capital Management, LLC | 2,373,841 | $6,267,000 | 2.28% |
Vivo Capital, LLC | 5,778,106 | $15,254,000 | 1.95% |
BVF INC/IL | 2,978,708 | $7,864,000 | 1.03% |
Boxer Capital, LLC | 2,913,091 | $7,691,000 | 0.95% |
NEA Management Company, LLC | 5,720,572 | $15,102,000 | 0.60% |
Perceptive Advisors | 4,400,440 | $11,617,000 | 0.44% |
INDUS CAPITAL PARTNERS, LLC | 631,513 | $1,667,000 | 0.30% |
BAILARD, INC. | 381,292 | $1,007,000 | 0.07% |
KNOTT DAVID M | 38,590 | $102,000 | 0.05% |